Denmark Sweden Norway Finland  Genzyme Danmark HomeKontaktGenzyme Corporate Home
OM OS
BEHANDLINGSOMRÅDER
PRODUKTER
Genzyme  
Genzyme er ét af verdens førende bioteknologiske firmaer og vores mål, er at forbedre livet for patienter med alvorlige sygdomme. Læs mere her
 
NYHEDER
Data from Genzyme’s Multiple Sclerosis Franchise Featured at AAN

CAMBRIDGE, Mass. – April 22, 2014 – Genzyme, a Sanofi company (EURONEXT: SAN and NYSE: SNY), announced today that 18 poster and oral presentations featuring Aubagio® (teriflunomide) and LemtradaTM (alemtuzumab) will be presented during the 66th American Academy of Neurology (AAN) Annual Meeting to be held in Philadelphia, April 26 – May 3, 2014.
Mere >

genzyme i
norden
genzyme
biosurgery
genzyme
corporation
 

Terms and Conditions Privacy Policy © 2008 Genzyme. All Rights Reserved. Webmaster